BioCryst Pharmaceuticals, Inc. Common Stock BCRX
i
Market dataready · fetched 2026-11-06T14:44:34.266Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T14:44:28.032594315Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-06T14:44:33.719438+00:00
BioCryst Pharmaceuticals, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 6.82 | 65.1% | 11.5% | |||
| 25Δ | 8.51 | 68.7% | 14.0% | 7.04 | 58.7% | 8.9% |
| 30Δ | 8.21 | 61.1% | 10.5% | 7.13 | 56.4% | 8.1% |
| 35Δ | 7.96 | 56.8% | 7.7% | 7.23 | 54.1% | 7.4% |
| 40Δ | 7.83 | 61.9% | 7.2% | 7.32 | 51.8% | 6.6% |
| 45Δ | 7.69 | 67.0% | 6.6% | 7.41 | 49.5% | 5.8% |
| 50Δ | 7.56 | 72.1% | 6.1% | 7.50 | 47.2% | 5.0% |
| 55Δ | 7.42 | 77.2% | 5.6% | 7.60 | 44.9% | 4.2% |
| 60Δ | 7.28 | 82.3% | 5.0% | 7.69 | 42.5% | 3.4% |
| 65Δ | 7.15 | 87.4% | 4.5% | 7.78 | 40.2% | 2.6% |
| 70Δ | 7.01 | 92.5% | 3.9% | 7.87 | 37.9% | 1.8% |
| 75Δ | 6.63 | 113.3% | 3.6% | 7.96 | 35.6% | 1.0% |
| 80Δ | 6.23 | 135.5% | 3.4% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.82
- IV
- 65.1%
- B/E move
- 11.5%
25Δ
- Pseudo strike
- 8.51
- IV
- 68.7%
- B/E move
- 14.0%
- Pseudo strike
- 7.04
- IV
- 58.7%
- B/E move
- 8.9%
30Δ
- Pseudo strike
- 8.21
- IV
- 61.1%
- B/E move
- 10.5%
- Pseudo strike
- 7.13
- IV
- 56.4%
- B/E move
- 8.1%
35Δ
- Pseudo strike
- 7.96
- IV
- 56.8%
- B/E move
- 7.7%
- Pseudo strike
- 7.23
- IV
- 54.1%
- B/E move
- 7.4%
40Δ
- Pseudo strike
- 7.83
- IV
- 61.9%
- B/E move
- 7.2%
- Pseudo strike
- 7.32
- IV
- 51.8%
- B/E move
- 6.6%
45Δ
- Pseudo strike
- 7.69
- IV
- 67.0%
- B/E move
- 6.6%
- Pseudo strike
- 7.41
- IV
- 49.5%
- B/E move
- 5.8%
50Δ
- Pseudo strike
- 7.56
- IV
- 72.1%
- B/E move
- 6.1%
- Pseudo strike
- 7.50
- IV
- 47.2%
- B/E move
- 5.0%
55Δ
- Pseudo strike
- 7.42
- IV
- 77.2%
- B/E move
- 5.6%
- Pseudo strike
- 7.60
- IV
- 44.9%
- B/E move
- 4.2%
60Δ
- Pseudo strike
- 7.28
- IV
- 82.3%
- B/E move
- 5.0%
- Pseudo strike
- 7.69
- IV
- 42.5%
- B/E move
- 3.4%
65Δ
- Pseudo strike
- 7.15
- IV
- 87.4%
- B/E move
- 4.5%
- Pseudo strike
- 7.78
- IV
- 40.2%
- B/E move
- 2.6%
70Δ
- Pseudo strike
- 7.01
- IV
- 92.5%
- B/E move
- 3.9%
- Pseudo strike
- 7.87
- IV
- 37.9%
- B/E move
- 1.8%
75Δ
- Pseudo strike
- 6.63
- IV
- 113.3%
- B/E move
- 3.6%
- Pseudo strike
- 7.96
- IV
- 35.6%
- B/E move
- 1.0%
80Δ
- Pseudo strike
- 6.23
- IV
- 135.5%
- B/E move
- 3.4%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 77.73% | |
| 61.99% | |
| 63.71% | |
| 69.01% | |
| 57.39% | |
| 54.28% | |
| 73.25% | |
| 82.27% | |
| 56.34% | |
| 57.27% |
Drug Manufacturers - Specialty & Generic
BHC
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of…
More →BIOA
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United States and Canada. The…
More →CGC
Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the…
More →COLL
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
More →CPIX
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and marketing of prescription products for hospital acute care,…
More →CRDL
Description unavailable
More →